• Cat-intel
  • MedIntelliX
  • Consulting
  • Resources
  • About Us
  • News
  • Careers
  • Contact Us
  • Login
    • Hero Background
    English
    Chinese
    French
    Japanese
    Korean
    German
    Spanish

    Cell Lysis Disruption Market Analysis

    ID: MRFR/HC/6886-HCR
    111 Pages
    Rahul Gotadki
    October 2025

    Cell Lysis and Disruption Market Research Report Information By Technique (Reagent Based, Physical Disruption), Product (Consumables, Instruments), Cell Type (Mammalian Cells, Microbial Cells) and End-User (Research Laboratories and Institutes) - Forecast to 2035

    Share:
    Download PDF ×

    We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

    Cell Lysis Disruption Market Infographic

    Purchase Options

    $ 4,950.0
    $ 5,950.0
    $ 7,250.0
    Compare License
    Summary Table of Contents Segmentation Download PDF

    Market Analysis

    In-depth Analysis of Cell Lysis Disruption Market Industry Landscape

    Technological developments are at the center of significant changes observed in this rapidly evolving market. The latter category consists of new reagents developed for various lysis methods as well as different instruments that make the whole process of cell lysis more efficient, predictable and amenable to scaling-up endeavors. There are other emerging technologies like bead milling ultrasonication pressure-based methods which add to versatility of cell lysis systems thereby enabling them used for many applications. It is also possible to integrate automation robotics streamline the workflow hence increasing flexibility precision in cells destruction processes. This solves not only issues around diverse types of samples but also enhances competition within this market. Technological developments are important drivers of change in this dynamic market.One of these areas is cell lysis whereby several innovations in lysis techniques, instrumentation and reagents have occurred leading to enhanced and reproducibility solutions that can be used for high-throughput purposes. These evolving technologies are making cell lysis systems versatile because they accommodate different approaches such as bead milling, ultrasonication, pressure based ones. The use of automation and robotics has further improved workflows thereby enabling greater flexibility in terms of cell disruption procedures hence allowing better precision. Consequently these technological advancements addresses not only some specific sample type related problems but also stimulates market competition. The market is dynamic due to diverse industries such as biopharmaceuticals, diagnostics and academic research. The need to develop biologics combined with an increasing interest in personalized medicine has necessitated efficient cell lysis processes . Such sample preparation methods have improved the diagnosis industry during molecular diagnostics and clinical testing. On the other hand, there has been a growing demand for cell lysis and disruption solutions within the field of biotechnology and pharmaceuticals due to their importance in R&D driven by this expanding marketplace. In terms of all these market dynamics, companies are influenced by such issues like samples compatibility or nature etc., optimization of lysis protocols, cost concerns as well as scalability. This means that one system should be applicable to various kinds of samples ranging from microbes up to mammalian cells.Use tissue homogenization protocol that will result in effective disruption without disturbing target molecules.The same holds true for costs and scale-up problems associated with industrial applications at large; which demands a continuous search for new innovative ideas or process improvements. Regulatory matters significantly shape market dynamics related to cell lysis and disruption products.It is therefore important for research or medical diagnostic institutions to meet quality standards validation needs together with regulatory guidelines so as not only safeguarding but also ensuring reliability of their products.These regulations must be met by manufacturers before they can receive approvals and certifications thereby dictating competitive landscape and positioning within the market. There are several leading life sciences companies as well as specialized manufacturers focusing on lysis reagents, instruments, integrated systems that compete within the market.Ease-of-use product innovation along with compatibility with different sample types when choosing among many alternatives are some ways through which these companies try to differentiate themselves. Strategic collaborations/partnerships aimed at expanding product portfolios while addressing different end users’ needs in various sectors have also become quite common.

    Market Summary

    The Global Cell Lysis and Disruption Market is projected to grow from 6.82 USD Billion in 2024 to 17.3 USD Billion by 2032.

    Key Market Trends & Highlights

    Cell Lysis and Disruption Key Trends and Highlights

    • The market is expected to experience a compound annual growth rate (CAGR) of 8.81% from 2025 to 2032.
    • By 2035, the market valuation is anticipated to reach 17.3 USD Billion, indicating robust growth potential.
    • In 2024, the market is valued at 6.82 USD Billion, reflecting a strong foundation for future expansion.
    • Growing adoption of advanced cell lysis technologies due to increasing research activities is a major market driver.

    Market Size & Forecast

    2024 Market Size 6.82 (USD Billion)
    2035 Market Size 17.3 (USD Billion)
    CAGR (2025-2035) 8.81%
    Largest Regional Market Share in 2024 latin_america)

    Major Players

    Thermo Fisher Scientific, Inc., Merck KGAA, Bio-Rad Laboratories, Inc., Danaher Corporation, Becton Dickinson & Company, Cell Signaling Technology, Inc., Miltenyi Biotec, Hoffmann–La Roche Ltd., Qiagen N.V., Qsonica, LLC

    Market Trends

    The ongoing advancements in biotechnology and molecular biology are driving a notable increase in the demand for efficient cell lysis and disruption techniques, which are essential for various applications in research and diagnostics.

    U.S. National Institutes of Health

    Cell Lysis Disruption Market Market Drivers

    Market Growth Projections

    The Global Cell Lysis and Disruption Market Industry is projected to experience substantial growth in the coming years. With an estimated market value of 6.82 USD Billion in 2024, the industry is expected to expand significantly, reaching 17.3 USD Billion by 2035. This growth trajectory suggests a compound annual growth rate (CAGR) of 8.81% from 2025 to 2035. Such projections indicate a robust demand for cell lysis technologies driven by advancements in biopharmaceuticals, personalized medicine, and life sciences research. The market's expansion reflects the increasing importance of effective cell disruption methods in various applications.

    Rising Demand for Biopharmaceuticals

    The increasing demand for biopharmaceuticals is a key driver of the Global Cell Lysis and Disruption Market Industry. As the biopharmaceutical sector expands, the need for effective cell lysis techniques to extract proteins and nucleic acids becomes paramount. This trend is underscored by the projected market value of 6.82 USD Billion in 2024, reflecting the growing investment in biopharmaceutical research and development. The ability to efficiently disrupt cell membranes is crucial for the production of therapeutic proteins, which are essential in treating various diseases. Consequently, advancements in lysis technologies are likely to play a pivotal role in meeting this demand.

    Growing Focus on Personalized Medicine

    The shift towards personalized medicine is significantly influencing the Global Cell Lysis and Disruption Market Industry. As healthcare moves towards tailored therapies, the need for precise and efficient cell lysis methods becomes critical. Personalized medicine relies on the analysis of individual patient cells, necessitating effective disruption techniques to extract relevant biomolecules. This trend is likely to drive investments in lysis technologies, as researchers seek to develop customized treatments. The market is projected to reach 17.3 USD Billion by 2035, highlighting the importance of cell lysis in the evolving landscape of personalized healthcare.

    Technological Advancements in Lysis Techniques

    Technological advancements in cell lysis and disruption methods are propelling the Global Cell Lysis and Disruption Market Industry forward. Innovations such as microfluidics and automated lysis systems enhance the efficiency and reproducibility of cell disruption processes. These technologies not only reduce the time required for lysis but also improve the yield of target biomolecules. As a result, researchers are increasingly adopting these advanced methods, which are expected to contribute to the market's growth. The anticipated compound annual growth rate (CAGR) of 8.81% from 2025 to 2035 indicates a robust trajectory for the industry, driven by these technological improvements.

    Increasing Research Activities in Life Sciences

    The rise in research activities within the life sciences sector is a significant driver of the Global Cell Lysis and Disruption Market Industry. As academic and industrial research institutions expand their focus on cellular biology, the demand for reliable cell lysis methods intensifies. This growth is reflected in the increasing number of publications and research grants dedicated to cell biology studies. Enhanced funding for life sciences research is likely to spur the development and adoption of advanced lysis technologies, further propelling market growth. The ongoing exploration of cellular mechanisms necessitates effective lysis solutions, thereby reinforcing the market's relevance.

    Regulatory Support for Biotechnology Innovations

    Regulatory support for biotechnology innovations is fostering growth in the Global Cell Lysis and Disruption Market Industry. Governments worldwide are implementing policies that encourage research and development in biotechnology, particularly in areas such as drug development and diagnostics. This supportive regulatory environment is likely to enhance funding opportunities for biotechnology firms, facilitating the advancement of cell lysis technologies. As these innovations gain traction, they are expected to contribute to the overall market expansion. The interplay between regulatory frameworks and technological advancements may create a conducive atmosphere for the growth of the cell lysis market.

    Market Segment Insights

    Regional Insights

    Key Companies in the Cell Lysis Disruption Market market include

    Industry Developments

    • Q2 2024: Thermo Fisher Scientific Launches New KingFisher Apex Purification System for Cell Lysis Applications Thermo Fisher Scientific announced the launch of its KingFisher Apex Purification System, designed to automate cell lysis and nucleic acid purification for research and clinical laboratories.
    • Q2 2024: Merck KGaA Opens New Bioprocessing Facility in Massachusetts to Expand Cell Lysis Reagent Production Merck KGaA inaugurated a new bioprocessing facility in Massachusetts, increasing its capacity for manufacturing cell lysis reagents used in biopharmaceutical production.
    • Q3 2024: QIAGEN Partners with Hamilton Robotics to Integrate Automated Cell Lysis Workflows QIAGEN announced a strategic partnership with Hamilton Robotics to co-develop automated cell lysis and sample preparation workflows for genomics and proteomics research.
    • Q3 2024: Beckman Coulter Life Sciences Acquires Cell Lysis Technology Startup LysiGen Beckman Coulter Life Sciences completed the acquisition of LysiGen, a startup specializing in advanced cell lysis technologies for single-cell analysis and bioprocessing.
    • Q4 2024: Promega Corporation Launches New Cell Lysis Buffer for High-Throughput Protein Extraction Promega Corporation introduced a new cell lysis buffer optimized for high-throughput protein extraction, targeting pharmaceutical and academic research labs.
    • Q4 2024: Sartorius AG Announces $100M Investment in Cell Lysis Instrument Manufacturing Expansion Sartorius AG revealed a $100 million investment to expand its manufacturing capabilities for cell lysis instruments at its Goettingen, Germany site.
    • Q1 2025: Thermo Fisher Scientific Receives CE Mark for New Cell Lysis Kit for Clinical Diagnostics Thermo Fisher Scientific received CE Mark approval for its latest cell lysis kit, enabling its use in clinical diagnostic laboratories across Europe.
    • Q1 2025: Bio-Rad Laboratories Appoints Dr. Lisa Chen as VP of Cell Lysis Product Development Bio-Rad Laboratories announced the appointment of Dr. Lisa Chen as Vice President of Cell Lysis Product Development, strengthening its leadership team in life sciences.
    • Q2 2025: Agilent Technologies Wins Major Contract to Supply Cell Lysis Systems to Leading Biotech Firm Agilent Technologies secured a multi-year contract to supply its cell lysis systems to a top biotechnology company for use in therapeutic protein production.
    • Q2 2025: Eppendorf Launches New Automated Cell Disruption Platform for Bioprocessing Eppendorf introduced an automated cell disruption platform designed to streamline cell lysis and extraction processes in bioprocessing applications.
    • Q3 2025: Roche Expands Cell Lysis Reagent Portfolio with Launch of FastLys Pro Roche announced the launch of FastLys Pro, a new reagent for rapid and efficient cell lysis, aimed at accelerating workflows in molecular biology labs.
    • Q3 2025: PerkinElmer Secures $30M Funding to Develop Next-Generation Cell Lysis Technologies PerkinElmer received $30 million in funding to advance research and development of next-generation cell lysis technologies for genomics and proteomics applications.

    Future Outlook

    Cell Lysis Disruption Market Future Outlook

    The Cell Lysis and Disruption Market is projected to grow at an 8.81% CAGR from 2024 to 2032, driven by advancements in biotechnology and increasing demand for personalized medicine.

    New opportunities lie in:

    • Invest in automated lysis systems to enhance throughput and efficiency in laboratories.
    • Develop novel reagents tailored for specific cell types to improve lysis effectiveness.
    • Explore partnerships with biotech firms to integrate lysis technologies in drug development processes.

    By 2035, the Cell Lysis and Disruption Market is expected to reach substantial growth, reflecting evolving industry needs.

    Market Segmentation

    Cell Lysis and Disruption Market Segmentation

    By Region
    • Americas: The largest regional market, increasing government initiatives to promote research in the pharmaceutical and biotech sector will boost the cell lysis and disruption market growth in this region. Firms in the US conduct over half the world's R&D in pharmaceuticals, which is about $75 billion and hold intellectual property rights on most new medicines.
    • Europe: Technological advancements in personalized medicine and proteomic field is leading to a rise in the adoption of cell lysis & disruption techniques.
    • Asia-Pacific: The fastest-growing regional market, Asia-Pacific is seeing a surge in the clinical trials and contract research and manufacturing activities owing to the growth in the bio-services sector is expected to boost the cell lysis and disruption market growth.
    • Middle East & Africa: The smallest market due to limited healthcare infrastructure in this region.
    By Product
    • Consumables: The fastest-growing segment owing to the increasing prevalence of diseases and rise in funding of cell-based research is a crucial factor for the growth of the segment. Consumables are further divided into reagent and kits, beads, and disposables.
    • Instruments: The commercial availability and reliability of tools that are used in cell disruption & lysis are boosting the growth of this segment. The instrument segment is further categorized as sonicators, homogenizers, French press, microfluidizer, and others.
    By End-User
    • Research Laboratories and Institutes: The largest segment, increased use of cell disruption techniques in research facilities is projected to drive the growth of this segment during the forecast period.
    • Pharmaceutical and Biotechnology Companies: A small segment due to the rising occurrence of diseases and growing research & development is projected to boost the growth of this segment.
    • Others: This segment includes academic and research institutions.
    By Cell Type
    • Mammalian Cells: The largest segment, this is attributable to Increased investments in R&D linked to biotechnology by government organizations and the private sector. Furthermore, the primary vital players have developed reagents that specifically work on mammalian cells, which is attributing to the growth of this segment. For instance, Merck offers a wide range of mammalian cell lysis reagents which are used for the preparation of mammalian phosphorylated, cytosolic, and nuclear proteins.
    • Microbial Cells: The expansion of the biopharmaceutical sector and increasing research is responsible for positive growth.
    • Others: This segment covers plant cells.
    By Technique
    • Reagent Based: The largest segment, higher biological specificity of enzymatic disruption is attributive to the growth of this segment size. The reagent based segment is further segmented into detergent and enzymatic.
    • Physical Disruption: Physical or mechanical methods of cell disruption have traditionally been the method of choice for cell lysis. Physical disruption method includes mechanical homogenization, ultrasonic homogenization, pressure homogenization, and temperature treatments.

    Report Scope

    Report Attribute/Metric Details
    Market Size 2023 6.28 (USD Billion)
    Market Size 2024 6.82 (USD Billion)
    Market Size 2032 13.40 (USD Billion)
    Compound Annual Growth Rate (CAGR) 8.81 % (2024 - 2032)
    Report Coverage Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
    Base Year 2023
    Market Forecast Period 2024 - 2032
    Historical Data 2018-2022
      Key Vendors   Thermo Fisher Scientific, Inc. (US), Merck KGAA (Germany), Bio-Rad Laboratories, Inc. (US), Danaher Corporation (US), Becton Dickinson & Company (US), Cell Signaling Technology, Inc. (US), Miltenyi Biotec (Germany), Hoffmann–La Roche Ltd. (Switzerland), Qiagen N.V. (Netherlands), Qsonica, LLC (US)
      Key Market Opportunities   New product launches and R&D Amongst major key Players
      Key Market Drivers ·  Expanding biotechnology and biopharmaceutical industries. ·  The increasing prevalence of chronic diseases, including cancer. ·  Increasing government funding for research ·  Rising focus on personalized medicine ·  Technological advancements in cell disruption techniques

    Market Highlights

    Author

    Rahul Gotadki
    Assistant Manager

    She holds an experience of about 6+ years in market research and business consulting, working under the spectrum of information communication technology, telecommunications and semiconductor domains. aarti conceptualizes and implements a scalable business strategy and provides strategic leadership to the clients. her expertise lies in market estimation, competitive intelligence, pipeline analysis, customer assessment, etc.

    Leave a Comment

    Latest Comments

    John Doe
    john@example.com

    This is a great article! Really helped me understand the topic better.

    Posted on July 23, 2025, 10:15 AM
    Jane Smith
    jane@domain.com

    Thanks for sharing this. I’ve bookmarked it for later reference.

    Posted on July 22, 2025, 7:45 PM
    View All

    FAQs

    What is the valuation of the Cell lysis disruption market?

    Cell lysis disruption market is expected to be valued at USD 13.40 Billion by 2032.

    What is the CAGR of the Cell lysis disruption market?

    The Cell lysis disruption market is expected to exhibit a strong 8.81% CAGR over the forecast period from 2024 to 2032.

    What is the major driver for the Cell lysis disruption market?

    Rising R&D activities in the biotechnology industry are the major driver for the cell lysis disruption market.

    Which is the leading regional market?

    The Americas are the leading regional market due to the presence of a strong biotech industry in the region.

    What are the key players in the Cell lysis disruption market?

    Leading players in the market include Merck, Danaher, and Becton Dickinson and Company, among others.

    1. Table of Contents
    2. REPORT PROLOGUE
    3. Market Introduction
      1. Definition
      2. Scope of the Study
        1. Research Objective
        2. Assumptions
        3. Limitations
    4. Research Methodology
      1. Overview
      2. Primary Research
      3. Secondary Research
      4. Market Size Estimation
    5. MARKET DYNAMICS
      1. Overview
      2. Drivers
      3. Restraints
      4. Opportunities
    6. MARKET FACTOR ANALYSIS
      1. Porter’s Five Forces Analysis
        1. Bargaining Power of Suppliers
        2. Bargaining Power of Buyers
        3. Threat of New Entrants
        4. Threat of Substitutes
        5. Intensity of Rivalry
      2. Value Chain Analysis
    7. GLOBAL CELL LYSIS & DISRUPTION MARKET, BY TECHNIQUE
      1. Overview
      2. Reagent Based
    8. Market Estimates & Forecast, by Region, 2020-2027
    9. Market Estimates & Forecast, by Country, 2020-2027
      1. Detergent
    10. Market Estimates & Forecast, by Country, 2020-2027
      1. Enzymatic
    11. Market Estimates & Forecast, by Region, 2020-2027
    12. Market Estimates & Forecast, by Country, 2020-2027
      1. Physical Disruption
    13. Market Estimates & Forecast, by Region, 2020-2027
      1. Mechanical Homogenization
    14. Market Estimates & Forecast, by Region, 2020-2027
      1. Ultrasonic Homogenization
        1. Pressure Homogenization
        2. Temperature Treatments
    15. Market Estimates & Forecast, by Region, 2020-2027
    16. GLOBAL CELL LYSIS & DISRUPTION MARKET, BY PRODUCT
      1. Overview
      2. Consumables
        1. Reagents and Kits
        2. Beads
    17. Market Estimates & Forecast, by Region, 2020-2027
    18. Market Estimates & Forecast, by Country, 2020-2027
      1. Disposables
    19. Market Estimates & Forecast, by Region, 2020-2027
      1. Instruments
        1. Sonicators
        2. Homogenizers
        3. French Press
        4. Microfluidizer
    20. Market Estimates & Forecast, by Country, 2020-2027
      1. Others
    21. GLOBAL CELL LYSIS & DISRUPTION MARKET, BY CELL TYPE
      1. Overview
      2. Mammalian Cells
      3. Microbial Cells
      4. Others
    22. GLOBAL CELL LYSIS & DISRUPTION MARKET, BY END USER
      1. Overview
      2. Research Laboratories and Institutes
      3. Others
    23. GLOBAL CELL LYSIS & DISRUPTION MARKET, BY REGION
      1. Overview
      2. Americas
        1. North America
        2. Latin America
      3. Europe
        1. Western Europe
        2. Eastern Europe
      4. Asia-Pacific
        1. Japan
        2. China
        3. India
        4. Australia
        5. South Korea
        6. Rest of Asia-Pacific
      5. Middle East & Africa
        1. Middle East
        2. Africa
    24. COMPANY LANDSCAPE
      1. Overview
      2. Competitive Analysis
      3. Market Share Analysis
      4. Major Growth Strategy in the Global Cell Lysis & Disruption Market
      5. Competitive Benchmarking
      6. Leading Players in terms of Number of Developments in the Global Cell Lysis & Disruption Market
      7. Key developments and Growth Strategies
        1. New Product Launch/Service Deployment
        2. Merger & acquisitions
        3. Joint Ventures
      8. Major Players Financial Matrix & Market Ratio
        1. Sales & Operating Income 2020
        2. Major Players R&D Expenditure 2020
      9. Major Players Capital Market Ratio
    25. COMPANY PROFILES
      1. Thermo Fisher Scientific, Inc.
        1. Company Overview
        2. Product Type Overview
        3. Financial Overview
        4. Key Developments
        5. SWOT Analysis
        6. Key Strategies
      2. Merck KGAA
        1. Company Overview
        2. Product Type Overview
        3. Financial Overview
        4. Key Developments
        5. SWOT Analysis
        6. Key Strategies
      3. Bio-Rad Laboratories, Inc.
        1. Company Overview
        2. Product Type Overview
        3. Financial Overview
        4. Key Developments
        5. SWOT Analysis
        6. Key Strategies
      4. Danaher Corporation
        1. Company Overview
        2. Product Type Overview
        3. Financial Overview
        4. Key Developments
        5. SWOT Analysis
        6. Key Strategies
      5. Becton Dickinson & Company
        1. Company Overview
        2. Product Type Overview
        3. Financial Overview
        4. Key Developments
        5. SWOT Analysis
        6. Key Strategies
      6. Cell Signaling Technology, Inc.
        1. Company Overview
        2. Product Type Overview
        3. Financial Overview
        4. Key Developments
        5. SWOT Analysis
        6. Key Strategies
      7. Miltenyi Biotec
        1. Company Overview
        2. Product Type Overview
        3. Financial Overview
        4. Key Developments
        5. SWOT Analysis
        6. Key Strategies
      8. F. Hoffmann–La Roche Ltd
        1. Company Overview
        2. Product Type Overview
        3. Financial Overview
        4. Key Developments
        5. SWOT Analysis
        6. Key Strategies
      9. Qiagen NV
        1. Company Overview
        2. Product Type Overview
        3. Financial Overview
        4. Key Developments
        5. SWOT Analysis
        6. Key Strategies
      10. Qsonica, LLC
        1. Company Overview
        2. Product Type Overview
        3. Financial Overview
        4. Key Developments
        5. SWOT Analysis
        6. Key Strategies
      11. Others
    26. APPENDIX
      1. References
      2. Related Reports
    27.  
    28. List of Tables and Figures
      1. LIST OF TABLES
      2. TABLE 1 GLOBAL CELL LYSIS & DISRUPTION MARKET SYNOPSIS, 2020-2027
      3. TABLE 2 GLOBAL CELL LYSIS & DISRUPTION MARKET ESTIMATES & FORECAST, 2020-2027 (USD MILLION)
      4. TABLE 3 GLOBAL CELL LYSIS & DISRUPTION MARKET, BY TECHNIQUE, 2020-2027 (USD MILLION)
      5. TABLE 4 GLOBAL CELL LYSIS & DISRUPTION MARKET, BY PRODUCT, 2020-2027 (USD MILLION)
      6. TABLE 5 GLOBAL CELL LYSIS & DISRUPTION MARKET, BY CELL TYPE, 2020-2027 (USD MILLION)
      7. TABLE 6 GLOBAL CELL LYSIS & DISRUPTION MARKET, BY END USER, 2020-2027 (USD MILLION)
      8. TABLE 7 GLOBAL CELL LYSIS & DISRUPTION MARKET, BY REGION, 2020-2027 (USD MILLION)
      9. TABLE 8 NORTH AMERICA: CELL LYSIS & DISRUPTION MARKET, BY TECHNIQUE, 2020-2027 (USD MILLION)
      10. TABLE 9 NORTH AMERICA: CELL LYSIS & DISRUPTION MARKET, BY PRODUCT, 2020-2027 (USD MILLION)
      11. TABLE 10 NORTH AMERICA: CELL LYSIS & DISRUPTION MARKET, BY CELL TYPE, 2020-2027 (USD MILLION)
      12. TABLE 11 NORTH AMERICA: CELL LYSIS & DISRUPTION MARKET, BY END USER, 2020-2027 (USD MILLION)
      13. TABLE 12 US: CELL LYSIS & DISRUPTION MARKET, BY TECHNIQUE, 2020-2027 (USD MILLION)
      14. TABLE 13 US: CELL LYSIS & DISRUPTION MARKET, BY PRODUCT, 2020-2027 (USD MILLION)
      15. TABLE 14 US: CELL LYSIS & DISRUPTION MARKET, BY CELL TYPE, 2020-2027 (USD MILLION)
      16. TABLE 15 US: CELL LYSIS & DISRUPTION MARKET, BY END USER, 2020-2027 (USD MILLION)
      17. TABLE 16 CANADA: CELL LYSIS & DISRUPTION MARKET, BY TECHNIQUE, 2020-2027 (USD MILLION)
      18. TABLE 17 CANADA: CELL LYSIS & DISRUPTION MARKET, BY PRODUCT, 2020-2027 (USD MILLION)
      19. TABLE 18 CANADA: CELL LYSIS & DISRUPTION MARKET, BY CELL TYPE, 2020-2027 (USD MILLION)
      20. TABLE 19 CANADA: CELL LYSIS & DISRUPTION MARKET, BY END USER, 2020-2027 (USD MILLION)
      21. TABLE 20 LATIN AMERICA: CELL LYSIS & DISRUPTION MARKET, BY TECHNIQUE, 2020-2027 (USD MILLION)
      22. TABLE 21 LATIN AMERICA: CELL LYSIS & DISRUPTION MARKET, BY PRODUCT, 2020-2027 (USD MILLION)
      23. TABLE 22 LATIN AMERICA: CELL LYSIS & DISRUPTION MARKET, BY CELL TYPE, 2020-2027 (USD MILLION)
      24. TABLE 23 LATIN AMERICA: CELL LYSIS & DISRUPTION MARKET, BY END USER, 2020-2027 (USD MILLION)
      25. TABLE 24 EUROPE: CELL LYSIS & DISRUPTION MARKET, BY TECHNIQUE, 2020-2027 (USD MILLION)
      26. TABLE 25 EUROPE: CELL LYSIS & DISRUPTION MARKET, BY PRODUCT, 2020-2027 (USD MILLION)
      27. TABLE 26 EUROPE: CELL LYSIS & DISRUPTION MARKET, BY CELL TYPE, 2020-2027 (USD MILLION)
      28. TABLE 27 EUROPE: CELL LYSIS & DISRUPTION MARKET, BY END USER, 2020-2027 (USD MILLION)
      29. TABLE 28 WESTERN EUROPE: CELL LYSIS & DISRUPTION MARKET, BY TECHNIQUE, 2020-2027 (USD MILLION)
      30. TABLE 29 WESTERN EUROPE: CELL LYSIS & DISRUPTION MARKET, BY PRODUCT, 2020-2027 (USD MILLION)
      31. TABLE 30 WESTERN EUROPE: CELL LYSIS & DISRUPTION MARKET, BY CELL TYPE, 2020-2027 (USD MILLION)
      32. TABLE 31 WESTERN EUROPE: CELL LYSIS & DISRUPTION MARKET, BY END USER, 2020-2027 (USD MILLION)
      33. TABLE 32 EASTERN EUROPE: CELL LYSIS & DISRUPTION MARKET, BY TECHNIQUE, 2020-2027 (USD MILLION)
      34. TABLE 33 EASTERN EUROPE: CELL LYSIS & DISRUPTION MARKET, BY PRODUCT, 2020-2027 (USD MILLION)
      35. TABLE 34 EASTERN EUROPE: CELL LYSIS & DISRUPTION MARKET, BY CELL TYPE, 2020-2027 (USD MILLION)
      36. TABLE 35 EASTERN EUROPE: CELL LYSIS & DISRUPTION MARKET, BY END USER, 2020-2027 (USD MILLION)
      37. TABLE 36 ASIA-PACIFIC: CELL LYSIS & DISRUPTION MARKET, BY TECHNIQUE, 2020-2027 (USD MILLION)
      38. TABLE 37 ASIA-PACIFIC: CELL LYSIS & DISRUPTION MARKET, BY PRODUCT, 2020-2027 (USD MILLION)
      39. TABLE 38 ASIA-PACIFIC: CELL LYSIS & DISRUPTION MARKET, BY CELL TYPE, 2020-2027 (USD MILLION)
      40. TABLE 39 ASIA-PACIFIC: CELL LYSIS & DISRUPTION MARKET, BY END USER, 2020-2027 (USD MILLION)
      41. TABLE 40 MIDDLE EAST & AFRICA: CELL LYSIS & DISRUPTION MARKET, BY TECHNIQUE, 2020-2027 (USD MILLION)
      42. TABLE 41 MIDDLE EAST & AFRICA: CELL LYSIS & DISRUPTION MARKET, BY PRODUCT, 2020-2027 (USD MILLION)
      43. TABLE 42 MIDDLE EAST & AFRICA: CELL LYSIS & DISRUPTION MARKET, BY CELL TYPE, 2020-2027 (USD MILLION)
      44. TABLE 43 MIDDLE EAST & AFRICA: CELL LYSIS & DISRUPTION MARKET, BY END USER, 2020-2027 (USD MILLION)   LIST OF FIGURES
      45. FIGURE 1 RESEARCH PROCES
      46. FIGURE 2 MARKET STRUCTURE FOR THE GLOBAL CELL LYSIS & DISRUPTION MARKET
      47. FIGURE 3 MARKET DYNAMICS FOR THE GLOBAL CELL LYSIS & DISRUPTION MARKET
      48. FIGURE 4 GLOBAL CELL LYSIS & DISRUPTION MARKET SHARE, BY TECHNIQUE, 2020 (%)
      49. FIGURE 5 GLOBAL CELL LYSIS & DISRUPTION MARKET SHARE, BY PRODUCT, 2020 (%)
      50. FIGURE 6 GLOBAL CELL LYSIS & DISRUPTION MARKET SHARE, BY CELL TYPE, 2020 (%)
      51. FIGURE 7 GLOBAL CELL LYSIS & DISRUPTION MARKET SHARE, BY END USER, 2020 (%)
      52. FIGURE 8 GLOBAL CELL LYSIS & DISRUPTION MARKET SHARE, BY REGION, 2020 (%)
      53. FIGURE 7 AMERICAS: CELL LYSIS & DISRUPTION MARKET SHARE BY REGION, 2020 (%)
      54. FIGURE 9 NORTH AMERICA: CELL LYSIS & DISRUPTION MARKET SHARE, BY COUNTRY, 2020 (%)
      55. FIGURE 10 EUROPE: CELL LYSIS & DISRUPTION MARKET SHARE, BY REGION, 2020 (%)
      56. FIGURE 11 WESTERN EUROPE: CELL LYSIS & DISRUPTION MARKET SHARE, BY COUNTRY, 2020 (%)
      57. FIGURE 12 ASIA-PACIFIC: CELL LYSIS & DISRUPTION MARKET SHARE, BY COUNTRY, 2020 (%)
      58. FIGURE 13 MIDDLE EAST & AFRICA: CELL LYSIS & DISRUPTION MARKET SHARE, BY COUNTRY, 2020 (%)
      59. FIGURE 14 GLOBAL CELL LYSIS & DISRUPTION MARKET: COMPANY SHARE ANALYSIS, 2020 (%)
      60. FIGURE 15 THERMO FISHER SCIENTIFIC, INC.: KEY FINANCIALS
      61. FIGURE 16 THERMO FISHER SCIENTIFIC, INC.: SEGMENTAL REVENUE
      62. FIGURE 17 THERMO FISHER SCIENTIFIC, INC.: REGIONAL REVENUE
      63. FIGURE 18 MERCK KGAA: KEY FINANCIALS
      64. FIGURE 19 MERCK KGAA: SEGMENTAL REVENUE
      65. FIGURE 20 MERCK KGAA: REGIONAL REVENUE
      66. FIGURE 21 BIO-RAD LABORATORIES, INC.: KEY FINANCIALS
      67. FIGURE 22 BIO-RAD LABORATORIES, INC.: SEGMENTAL REVENUES
      68. FIGURE 23 BIO-RAD LABORATORIES, INC.: REGIONAL REVENUE
      69. FIGURE 24 DANAHER CORPORATION: KEY FINANCIALS
      70. FIGURE 25 DANAHER CORPORATION: SEGMENTAL REVENUE
      71. FIGURE 26 DANAHER CORPORATION: REGIONAL REVENUE
      72. FIGURE 27 BECTON DICKINSON & COMPANY: KEY FINANCIALS
      73. FIGURE 28 BECTON DICKINSON & COMPANY: SEGMENTAL REVENUE
      74. FIGURE 29 BECTON DICKINSON & COMPANY: REGIONAL REVENUE
      75. FIGURE 30 CELL SIGNALING TECHNOLOGY, INC.: KEY FINANCIALS
      76. FIGURE 31 CELL SIGNALING TECHNOLOGY, INC.: SEGMENTAL REVENUE
      77. FIGURE 32 CELL SIGNALING TECHNOLOGY, INC.: REGIONAL REVENUE
      78. FIGURE 33 MILTENYI BIOTEC: KEY FINANCIALS
      79. FIGURE 34 MILTENYI BIOTEC: SEGMENTAL REVENUE
      80. FIGURE 35 MILTENYI BIOTEC: REGIONAL REVENUE
      81. FIGURE 36 F. HOFFMANN–LA ROCHE LTD: KEY FINANCIALS
      82. FIGURE 37 F. HOFFMANN–LA ROCHE LTD: SEGMENTAL REVENUE
      83. FIGURE 38 F. HOFFMANN–LA ROCHE LTD: REGIONAL REVENUE
      84. FIGURE 39 QIAGEN NV: KEY FINANCIALS
      85. FIGURE 40 QIAGEN NV: SEGMENTAL REVENUE
      86. FIGURE 41 QIAGEN NV: REGIONAL REVENUE
      87. FIGURE 42 QSONICA, LLC: KEY FINANCIALS
      88. FIGURE 43 QSONICA, LLC: SEGMENTAL REVENUE
      89. FIGURE 44 QSONICA, LLC: REGIONAL REVENUE

    Cell Lysis and Disruption Market Segmentation

    Market Segmentation Overview

    • Detailed segmentation data will be available in the full report
    • Comprehensive analysis by multiple parameters
    • Regional and country-level breakdowns
    • Market size forecasts by segment
    Infographic

    Free Sample Request

    Kindly complete the form below to receive a free sample of this Report

    Get Free Sample

    Related Reports

    Regional Reports
    Country Reports

    Customer Strories

    “I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”

    Victoria Milne

    Founder
    Case Study
    Chemicals and Materials
    Global Magnesium Sulfate Market – Forecast till 2027